Clinical Trial Update: Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preventive inhalation of hypertonic saline in infants with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Hypertonic saline inhalation (Hypertonic saline)

Snippet

Sponsor: Heidelberg University | Conditions: Cystic Fibrosis Lung Disease | Phase 2 | Status: COMPLETED